Preparation for the relief of disease
AssigneeAkl Technologies Limited
InventorNicholas J. Larkins
Life of this patent
Estimating the term…
Abstract
A composition including (a) a Platelet Activating Factor (PAF) Inhibitor and (b) an antioxidant which interferes with the arachidonic acid cascade and also has antioxidant activity. The composition is useful for the treatment or the relief of inflammatory diseases, thrombosis, cardiac problems, and/or conditions caused by platelet induced blood clotting.
Claims20
A pharmaceutical composition comprising a unitary dose of ginkgo biloba equivalent to between 1 mg/kg bodyweight and 25 mg/kg body weight ginkgo biloba, standardized to 24% ginkgo flavone glycosides, and a unitary dose of apocynin of between 60 μg/kg body weight and 20 mg/kg body weight.
A composition including apocynin, picrorrhiza kurroa, standardized to a minimum of 2% Kutkin;
- lactoferrin;
- ginkgo biloba, standardized to 18% ginkgo flavone glycosides;
- bee pollen;
- chlorella pyrenoidosa;
- phosphatidylcholine;
- and fucus vesiculosus in the parts by weight ratio of 100:200:60:150:120:250:100:20.
A composition including apocynin, picrorrhiza kurroa, standardized to a minimum of 2% Kutkin;
- ginkgo biloba, standardized to 24% ginkgo flavone glycosides;
- chlorella pyrenoidosa;
- and phosphatidylcholine in the parts by weight ratio of 180:360:260:100:100.
A composition including apocynin, picrorrhiza kurroa, standardized to a minimum of 2% Kutkin;
- lactoferrin;
- ginkgo biloba, standardized to 24% ginkgo flavone glycosides;
- bee pollen;
- chlorella pyrenoidosa;
- phosphatidylcholine;
- and fucus vesiculosus in the parts by weight ratio of 100:200:150:100:280:150:20.
Dependencies are inferred from the claim text.